002788.SZ - Luyan Pharma Co.,Ltd.

Shenzhen - Shenzhen Delayed Price. Currency in CNY
  • Dividend

    002788.SZ announced a cash dividend of 0.30 with an ex-date of Jun. 14, 2023

Luyan Pharma Co.,Ltd.

No. 1004, Anling Road
Huli District
Xiamen 361015
China
86 59 2812 8888
https://www.luyan.com.cn

Sector(s)Healthcare
IndustryPharmaceutical Retailers
Full Time Employees5,286

Key Executives

NameTitlePayExercisedYear Born
Mr. Jinxiang WuChairman & GMN/AN/A1962
Ms. Congjin YangCFO & Non-Independent DirectorN/AN/A1969
Mr. Lei MingDeputy GM, Chief Compliance Officer & DirectorN/AN/A1975
Mr. Quanqing YeSec.N/AN/A1977
Mr. Jin LiuDeputy Gen. Mang.N/AN/A1975
Ms. Cuiping LiMang. of Auditing Department & SupervisorN/AN/A1980
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.

Description

Luyan Pharma Co.,Ltd. engages in the research and development, production, and sale of human health products in China. It also operates pharmaceutical distribution and retail direct stores. The company was formerly known as Luyan (Fujian) Pharma Co. Ltd. and changed its name to Luyan Pharma Co.,Ltd. in June 2016. Luyan Pharma Co.,Ltd. was founded in 1992 and is headquartered in Xiamen, China.

Corporate Governance

Luyan Pharma Co.,Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.